A new study explores the connection between exercise and the expression of MYC in skeletal muscles over time, showing that small doses can drive muscle growth without exercise.

Olema Pharmaceuticals prepares for its OPERA-02 study, targeting ER+/HER2- breast cancer. Read why OLMA stock could benefit ...

Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...